ArticleCancer chemotherapy and pharmacology2021

Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors.

Chika Nitani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.